You just read:

Halaven® (Eribulin) Remains Available for Patients with Advanced Metastatic Breast Cancer Who Have Progressed After at Least Two Chemotherapeutic Regimens Despite Recent NICE Draft Guidance in an Earlier Setting

News provided by

Eisai

30 Nov, 2017, 16:37 GMT